464 related articles for article (PubMed ID: 11752061)
1. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
[TBL] [Abstract][Full Text] [Related]
2. Effects of glial glutamate transporter inhibitors on intracellular Na+ in mouse astrocytes.
Chatton JY; Shimamoto K; Magistretti PJ
Brain Res; 2001 Mar; 893(1-2):46-52. PubMed ID: 11222991
[TBL] [Abstract][Full Text] [Related]
3. Transient increase in the high affinity [3H]-L-glutamate uptake activity during in vitro development of hippocampal neurons in culture.
Gaillet S; Plachez C; Malaval F; Bézine MF; Récasens M
Neurochem Int; 2001 Apr; 38(4):293-301. PubMed ID: 11137623
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of DL-threo-beta-benzyloxyaspartate (DL-TBOA) and L-trans-pyrrolidine-2,4-dicarboxylate (t-2,4-PDC) on uptake and release of [3h]D-aspartate in astrocytes and glutamatergic neurons.
Waagepetersen HS; Shimamoto K; Schousboe A
Neurochem Res; 2001 Jun; 26(6):661-6. PubMed ID: 11519725
[TBL] [Abstract][Full Text] [Related]
6. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures.
Chen Y; Swanson RA
J Neurochem; 2003 Mar; 84(6):1332-9. PubMed ID: 12614333
[TBL] [Abstract][Full Text] [Related]
7. SNARE protein-dependent glutamate release from astrocytes.
Araque A; Li N; Doyle RT; Haydon PG
J Neurosci; 2000 Jan; 20(2):666-73. PubMed ID: 10632596
[TBL] [Abstract][Full Text] [Related]
8. Glutamate uptake shapes low-[Mg2+] induced epileptiform activity in juvenile rat hippocampal slices.
Nyitrai G; Lasztóczi B; Kardos J
Brain Res; 2010 Jan; 1309():172-8. PubMed ID: 19912995
[TBL] [Abstract][Full Text] [Related]
9. Glutamate transport blockade has a differential effect on AMPA and NMDA receptor-mediated synaptic transmission in the developing barrel cortex.
Kidd FL; Isaac JT
Neuropharmacology; 2000 Mar; 39(5):725-32. PubMed ID: 10699439
[TBL] [Abstract][Full Text] [Related]
10. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate.
Phillis JW; Ren J; O'Regan MH
Brain Res; 2000 Jun; 868(1):105-12. PubMed ID: 10841893
[TBL] [Abstract][Full Text] [Related]
11. The role of inversely operating glutamate transporter in the paradoxical analgesia produced by glutamate transporter inhibitors.
Kim WM; Chae JW; Heo BH; Park KS; Kim HS; Lee HG; Choi JI; Yoon MH
Eur J Pharmacol; 2016 Dec; 793():112-118. PubMed ID: 27838398
[TBL] [Abstract][Full Text] [Related]
12. Gliotoxicity in hippocampal cultures is induced by transportable, but not by nontransportable, glutamate uptake inhibitors.
Guiramand J; Martin A; de Jesus Ferreira MC; Cohen-Solal C; Vignes M; Récasens M
J Neurosci Res; 2005 Jul; 81(2):199-207. PubMed ID: 15931685
[TBL] [Abstract][Full Text] [Related]
13. Role of glutamine and neuronal glutamate uptake in glutamate homeostasis and synthesis during vesicular release in cultured glutamatergic neurons.
Waagepetersen HS; Qu H; Sonnewald U; Shimamoto K; Schousboe A
Neurochem Int; 2005 Jul; 47(1-2):92-102. PubMed ID: 15921825
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
Bozzo L; Chatton JY
Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
[TBL] [Abstract][Full Text] [Related]
16. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
[TBL] [Abstract][Full Text] [Related]
17. The competitive transport inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition.
Volterra A; Bezzi P; Rizzini BL; Trotti D; Ullensvang K; Danbolt NC; Racagni G
Eur J Neurosci; 1996 Sep; 8(9):2019-28. PubMed ID: 8921292
[TBL] [Abstract][Full Text] [Related]
18. Na+-dependent high-affinity glutamate transport in macrophages.
Rimaniol AC; Haïk S; Martin M; Le Grand R; Boussin FD; Dereuddre-Bosquet N; Gras G; Dormont D
J Immunol; 2000 May; 164(10):5430-8. PubMed ID: 10799909
[TBL] [Abstract][Full Text] [Related]
19. Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons.
Himi T; Ikeda M; Yasuhara T; Murota SI
J Neurosci Res; 2003 Mar; 71(5):679-88. PubMed ID: 12584726
[TBL] [Abstract][Full Text] [Related]
20. L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters.
Griffiths R; Dunlop J; Gorman A; Senior J; Grieve A
Biochem Pharmacol; 1994 Jan; 47(2):267-74. PubMed ID: 7905733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
